Professor, Neurology, Mayo Medical School
Neurology
Dr. Peter J. Dyck, MD
|
|
Give Review
Peter Dyck is an expert in the field of Neurology. Peter Dyck has written publications. He has 64 publications published with PubMed. The lastest paper is: 'Vasculitic neuropathy following exposure to minocycline.' He accepts all Medicare patients.
Publications
- Paraspinal neurofibromas and hypertrophic Neuropathy in Noonan syndrome with multiple lentigines.
- Vasculitic Neuropathy following exposure to minocycline.
- Defects of mutant DNMT1 are linked to a spectrum of neurological Disorders.
- Progressive polyradiculoNeuropathy due to intraneural oxalate deposition in type 1 primary hyperoxaluria.
- Exploring the Role of Tanezumab as a Novel Treatment for the Relief of Neuropathic Pain.
- Nerve safety of tanezumab, a Nerve growth factor inhibitor for pain treatment.
- Aberrant signature methylome by DNMT1 hot spot mutation in hereditary sensory and Autonomic neuropathy 1E.
- Application of whole exome sequencing in undiagnosed inherited polyneuropathies.
- Proficiency of Nerve conduction using standard methods and reference values (Cl. NPhys Trial 4).
- Repurposing diflunisal for familial amyloid Polyneuropathy: a randomized clinical trial.
- Assessing decreased sensation and increased sensory phenomena in Diabetic polyneuropathies.
- Value of quantitative sensory testing in neurological and pain Disorders: NeuPSIG consensus.
- Novel SOD1 mutation Discovered in atypical ALS by whole exome sequencing.
- A multicenter trial of the proficiency of smart quantitative sensation tests.
- DNMT1 mutation hot spot causes varied phenotypes of HSAN1 with dementia and hearing loss.
- A trial of proficiency of Nerve conduction: Greater standardization still needed.
- Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia.
- Surgical and postpartum hereditary Brachial plexus attacks and prophylactic immunotherapy.
- Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.
- A controlled study of medial arterial calcification of legs: implications for Diabetic polyneuropathy.
- Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved Nerve mitochondria.
- Modeling nerve conduction criteria for diagnosis of Diabetic polyneuropathy.
- Efficacy and Safety of Antioxidant Treatment With {alpha}-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 Trial.
- Mutations in DNMT1 cause hereditary sensory Neuropathy with dementia and hearing loss.
- Mass spectrometric-based proteomic analysis of amyloid Neuropathy type in nerve tissue.
- Motor neuron disease due to Neuropathy target esterase gene mutation: clinical features of the index families.
- Painless diabetic motor neuropathy: A variant of diabetic lumbosacral radiculoPlexus Neuropathy?
- Inflammatory pseudotumor of nerve: clinicopathological characteristics and a potential therapy.
- Primary amyloidosis presenting as upper limb multiple mononeuropathies.
- Scapuloperoneal spinal muscular atrophy and CMT2C are allelic Disorders caused by alterations in TRPV4.
- Quantitative sensation and Autonomic test abnormalities in transthyretin amyloidosis polyneuropathy.
- Skin biopsy for peripheral Neuropathy: is it better to punch or to blister?
- Dynametric assessment in CIDP.
- SEPT9 mutations and a conserved 17q25 sequence in sporadic and hereditary Brachial plexus neuropathy.
- Late-onset HMSN 2: further evidence of genetic heterogeneity.
- In memoriam: P.K. Thomas, MD (1926-2008).
- Misdirection of regenerating motor axons after Nerve injury and repair in the rat sciatic Nerve model.
- Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of Neuropathy in rare patients.
- Enumerating Meissner corpuscles: future gold standard of large fiber sensorimotor Polyneuropathy?
- Hemorrhagic Polyneuropathy in idiopathic thrombocytopenic purpura.
- The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism.
- Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity.
- Does impaired glucose metabolism cause Polyneuropathy? Review of previous studies and design of a prospective controlled population-based study.
- Oral treatment with alpha-lipoic acid improves symptomatic Diabetic polyneuropathy: the SYDNEY 2 trial.
- Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes.
- Anesthesia and patients with congenital hyposensitivity to pain.
- Effects of duration of type 2 diabetes mellitus on insulin secretion.
- Vascular endothelial growth factor and POEMS.
- Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features.
- Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of Polyneuropathy.
- History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation.
- Genetic testing in inherited Peripheral neuropathies.
- Autonomic symptoms and diabetic neuropathy: a population-based study.
- Identification of transthyretin variants by sequential proteomic and genomic analysis.
- Adult polyglucosan body disease: case description of an expanding genetic and clinical syndrome.
- Multifocal motor Neuropathy: pathologic alterations at the site of conduction block.
- Indifference rather than insensitivity to pain.
- Individual attributes versus composite scores of Nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment.
- Microfluidic chip-based method for genotyping microsatellites, VNTRs and insertion/deletion polymorphisms.
- Quantitative sensation testing in small-diameter sensory fiber Neuropathy.
- Clinical versus quantitative vibration assessment: improving clinical performance.
- Rapidly progressive amyloid Polyneuropathy associated with a novel variant transthyretin serine 25.
- Methodology for conduct of epidemiologic surveys and randomized controlled trials of Diabetic polyneuropathy.
Schools
University Of Toronto Faculty Of Medicine
University Hospital
Conditions Treated
- Ataxia
- Autonomic Disorders
- Brachial Plexus Palsy
- Diabetic PolyNeuropathy
- View All
Doctors Specialties
- Neurology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
Education
-
Mayo School of Graduate Medical Education -
University of Toronto Faculty of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922086164 |
| Last Name Of The Provider | DYCK |
| First Name Of The Provider | PETER |
| View All |
Similar Doctors
|
|
Dr. Phillip A. Low, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Edward C. Leung, MD |
|
|
Dr. Squire M. Stead, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. J E. Ahlskog, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Orhun H. Kantarci, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Gabriele C. De Luca, MD |
|
|
Dr. Luis E. Bello-Espinosa, MD |
|
|
Dr. Christopher J. Boes, MD |
|
|
Dr. David B. Burkholder, MD |
|
|
Dr. Deena M. Nasr, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin E. Norby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Cory J. Kogelschatz
This Doctor is OpenDoctor Recommended.
|
|
|
David A. Magezi, MB CHB |